| Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry L Snyder, ML Neely, AS Hellkamp, E O’Brien, J De Andrade, ... Respiratory research 20, 1-10, 2019 | 59 | 2019 |
| Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry ML Salisbury, CS Conoscenti, DA Culver, E Yow, ML Neely, S Bender, ... Annals of the American Thoracic Society 17 (11), 1413-1423, 2020 | 38 | 2020 |
| Disease severity and quality of life in patients with idiopathic pulmonary fibrosis: A cross-sectional analysis of the IPF-PRO Registry EC O’Brien, AS Hellkamp, ML Neely, A Swaminathan, S Bender, ... Chest 157 (5), 1188-1198, 2020 | 29 | 2020 |
| In-hospital mortality in patients with idiopathic pulmonary fibrosis: a US cohort study MT Durheim, J Judy, S Bender, D Baumer, J Lucas, SB Robinson, ... Lung 197, 699-707, 2019 | 29 | 2019 |
| Safety of nintedanib in patients with idiopathic pulmonary fibrosis: global pharmacovigilance data JA Lasky, GJ Criner, HM Lazarus, V Kohlbrenner, S Bender, L Richeldi Advances in Therapy 37, 4209-4219, 2020 | 26 | 2020 |
| Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States Y Fan, S Bender, W Shi, D Zoz Journal of Managed Care & Specialty Pharmacy 26 (12), 1539-1547, 2020 | 25 | 2020 |
| Changes in Body Composition, Muscle Strength, and Fat Distribution Following Kidney Transplantation T Dienemann, SL Ziolkowski, S Bender, S Goral, J Long, JF Baker, ... American Journal of Kidney Diseases 78 (6), 816-825, 2021 | 23 | 2021 |
| Time to Diagnosis of Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry LD Snyder, C Mosher, CH Holtze, LH Lancaster, KR Flaherty, I Noth, ... A102. ILD DIAGNOSIS AND MONITORING, A2565-A2565, 2020 | 21 | 2020 |
| Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes … AH Case, AS Hellkamp, ML Neely, S Bender, DF Dilling, M Gulati, ... Annals of the American Thoracic Society 17 (6), 699-705, 2020 | 20 | 2020 |
| Disparities in lung transplant among patients with idiopathic pulmonary fibrosis: an analysis of the IPF-PRO Registry AC Swaminathan, AS Hellkamp, ML Neely, S Bender, L Paoletti, ES White, ... Annals of the American Thoracic Society 19 (6), 981-990, 2022 | 16 | 2022 |
| Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States ML Hanna, D Singer, SD Bender, WC Valdecantos, JJ Wu Current Medical Research and Opinion 37 (10), 1697-1703, 2021 | 16 | 2021 |
| Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial GD Goss, M Cobo, S Lu, K Syrigos, KH Lee, E Göker, V Georgoulias, ... EClinicalMedicine 37, 2021 | 15 | 2021 |
| Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry Y Fan, SD Bender, CS Conoscenti, L Davidson-Ray, PA Cowper, ... Chest 157 (6), 1522-1530, 2020 | 14 | 2020 |
| Hospitalizations in patients with idiopathic pulmonary fibrosis HJ Kim, LD Snyder, A Adegunsoye, ML Neely, S Bender, ES White, ... Respiratory research 22 (1), 1-9, 2021 | 13 | 2021 |
| Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial F Saran, L Welsh, A James, C McBain, R Gattamaneni, S Jefferies, ... Journal of Neuro-oncology 155, 307-317, 2021 | 12 | 2021 |
| Characteristics of patients with idiopathic pulmonary fibrosis (IPF) in the US: data from the IPF-PRO registry D Culver, E Yow, M Neely, J Belperio, S Bender, J De Andrade, J Roman, ... Chest 154 (4), 397A-398A, 2018 | 12 | 2018 |
| Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis JA de Andrade, ML Neely, AS Hellkamp, DA Culver, HJ Kim, T Liesching, ... Clinical Therapeutics 45 (4), 306-315, 2023 | 9 | 2023 |
| A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018 MT Durheim, J Judy, S Bender, ML Neely, D Baumer, SB Robinson, ... Medicine 99 (47), e23143, 2020 | 9 | 2020 |
| Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry investigators. Disparities in lung transplant among patients with idiopathic pulmonary fibrosis: an analysis of the … AC Swaminathan, AS Hellkamp, ML Neely, S Bender, L Paoletti, ES White, ... Ann Am Thorac Soc 19 (6), 981-990, 2022 | 6 | 2022 |
| Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry JA de Andrade, T Kulkarni, ML Neely, AS Hellkamp, AH Case, ... Respiratory medicine 189, 106637, 2021 | 6 | 2021 |
